HSP90B2P and glioblastoma: As the subsequent upregulation of HSP client proteins diminished the cytotoxic effect of CBD, the authors proposed that the inclusion of HSP inhibitors might enhance the anti-tumor effects of cannabinoids in glioma/GBM treatment regimens (Scott et al., 2015).